Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VIII inhibitors: in vivo decrease of inhibitory activity during calcium infusion.

A F Muhleman, H I Glueck, M A Miller

    American Journal of Hematology
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of Pellagra with Nicotinic Acid.

    British medical journal·2010
    Same author

    Platelet sodium/hydrogen exchanger activity in normotensives and hypertensives.

    Clinica chimica acta; international journal of clinical chemistry·1999
    Same author

    Galanin antagonizes vasopressin-stimulated flank marking in male golden hamsters.

    Brain research·1999
    Same author

    Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities.

    Infection control and hospital epidemiology·1999
    Same author

    More on measles.

    Public health reports (Washington, D.C. : 1974)·1999
    Same author

    Simple strategy for direct identification of medically important yeast species from positive blood culture vials.

    Journal of clinical microbiology·1999

    Parenteral calcium administration reduced the activity of factor VIII inhibitors in patients. This effect was enhanced when calcium was given before and during factor VIII replacement therapy.

    Area of Science:

    • Hematology
    • Biochemistry

    Background:

    • Factor VIII inhibitors pose a significant challenge in managing hemophilia and other bleeding disorders.
    • Understanding modulators of factor VIII inhibitor activity is crucial for developing novel therapeutic strategies.

    Observation:

    • The study investigated the impact of parenteral calcium on factor VIII inhibitor activity in three patients.
    • Patients received intravenous calcium, factor VIII replacement, or a combination of both.

    Findings:

    • Intravenous calcium infusion, particularly when administered before and during factor VIII replacement, led to a greater reduction in factor VIII inhibitor activity.
    • This effect was confirmed using conventional coagulation assays and an agarose gel method.

    Implications:

    Related Experiment Videos

    • Parenteral calcium may offer a novel therapeutic approach to mitigate factor VIII inhibitor activity.
    • Further research into the calcium-factor VIII interaction could elucidate mechanisms relevant to bleeding disorders.